Shuer Fen (舒尔芬)舒尔芬
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山西省太原晋阳制药厂Chinese legal name: 山西省太原晋阳制药厂
主要成分Active Ingredients
- HO
- 每片含双氯芬酸钠(CHClNNaORecorded Chinese composition: 每片含双氯芬酸钠(CHClNNaO
药物知识说明
HO是一种在国家药监局注册认定的药品。该药品含有ho-b5d9b591等成分。
该药品关联的活性成分包括：ho。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：山西省太原晋阳制药厂Chinese legal name: 山西省太原晋阳制药厂。
您可以探索含有相同成分的其他药品：ho-b5d9b591成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
HO is a medicine registered with the national drug regulatory authority. It contains ho as active ingredient(s).
Active ingredients associated with this product: ho.
Manufacturers recorded for this product: 山西省太原晋阳制药厂Chinese legal name: 山西省太原晋阳制药厂.
Explore other medicines containing the same ingredient: ho products.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 舒尔芬Recorded Chinese name: 舒尔芬
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 每片含磷酸可待因15mg,双氯芬酸钠25mgRecorded Chinese composition: 每片含磷酸可待因15mg,双氯芬酸钠25mg
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 山西省太原晋阳制药厂Chinese legal name: 山西省太原晋阳制药厂
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H10950229
关联实体Relationships
相关问题Questions
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H10950229
Manufacturer
Chinese legal name: 山西省太原晋阳制药厂 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H10950229
生产企业
山西省太原晋阳制药厂(国产)
适应症
本品为复方中度镇痛药。用于治疗骨病疼痛(骨关节痛、骨折疼痛、骨科手术疼痛和癌症骨转移疼痛等)、神经痛、(三叉神经痛、坐骨神经痛、肩臂痛、腰骶神经痛等)、手术后疼痛、牙痛、痛经及癌痛。可作为癌症三阶段梯止痛治疗中的第二阶梯用药。
用法用量
口服。 1.成人1次1～2片，1日3次。 2.儿童1日每公斤体重3.5～6mg(每片按40mg计算)，在医生指导下，多次服用。 3.连续使用不超过7天。
不良反应
1.主要为胃肠道症状，如胃部不适、恶心、呕吐等，发生率约为10%左右。
2.文献报道还可有头晕、困倦、皮疹、瘙痒、水肿、黄疸、便秘或出血倾向等。
禁忌
1.肝、肾损害，有消化性溃疡病史者以及哺乳期妇女慎用。
2.妊娠头三个月及有阿司匹林、吗啡过敏者忌用。
3.心因性、功能性与诊断不明的疼痛禁用。
注意事项
1.本品为国家特殊管理的第二类精神药品，必须严格遵守国家对精神药品的管理条例，按规定开写精神药品处方和供应、管理本类药品，防止滥用。
2.应注意消化道溃疡、肾损害或成瘾性的发生，但这些现象大都是长期、大剂量应用时才有出现的可能。
3.肝、肾损害，有消化性溃疡病史者慎用。
贮藏
遮光，密闭保存
规格
每片含磷酸可待因15mg,双氯芬酸钠25mg
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.